Paraneoplastic pemphigus

Dermatologica Sinica

Volumn 28, Issue 1, 2010, Pages 1-14

  Lee, Sang Eun ^a   Kim, Soo Chan ^a  

^a Yonsei University College of Medicine   (South Korea)

Author keywords

Autoantibodies to plakin and desmoglein; Cellular immunity; Humoral immunity; Paraneoplastic pemphigus

Indexed keywords

ALEMTUZUMAB; ANTIGEN; AUTOANTIBODY; AZATHIOPRINE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN; DACLIZUMAB; DESMOGLEIN 1; DESMOGLEIN 3; DESMOGLEIN 3 ANTIBODY; DESMOGLEIN ANTIBODY; ENVOPLAKIN; EPITHELIAL MEMBRANE ANTIGEN; EPITOPE; IMMUNOGLOBULIN; IMMUNOSUPPRESSIVE AGENT; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PERIPLAKIN; PLAKIN; PREDNISONE; RITUXIMAB;

ACANTHOLYSIS; ANGIOFOLLICULAR LYMPH NODE HYPERPLASIA; ANTIBODY DETECTION; ANTIBODY PRODUCTION; AUTOIMMUNE DISEASE; BLISTER; BREAST ADENOCARCINOMA; BRONCHIOLITIS OBLITERANS; BRONCHUS CANCER; CANCER MORTALITY; CD8+ T LYMPHOCYTE; CELL DEATH; CELLULAR IMMUNITY; CHILL; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL FEATURE; COLON ADENOCARCINOMA; CROSS REACTION; CYTOKINE PRODUCTION; CYTOTOXIC T LYMPHOCYTE; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG ERUPTION; DRUG FEVER; DRUG INDUCED HEADACHE; DRUG MEGADOSE; ENDOMETRIUM CARCINOMA; ENZYME LINKED IMMUNOSORBENT ASSAY; GASTROINTESTINAL HEMORRHAGE; GOLD STANDARD; HISTOLOGY; HODGKIN DISEASE; HUMAN; HUMORAL IMMUNITY; HYPOTENSION; IMMUNOBLOTTING; IMMUNOFLUORESCENCE; IMMUNOPATHOLOGY; IMMUNOPRECIPITATION; KERATINOCYTE; KIDNEY CARCINOMA; LARGE CELL LYMPHOMA; LEIOMYOSARCOMA; LICHENOID; LIPOSARCOMA; LIVER CARCINOMA; LYMPHATIC SYSTEM TUMOR; LYMPHOPROLIFERATIVE DISEASE; MORPHOLOGY; MUCOSA INFLAMMATION; MULTIPLE ORGAN FAILURE; NEOPLASM; NERVE SHEATH TUMOR; NONHODGKIN LYMPHOMA; OPPORTUNISTIC INFECTION; PANCREAS ADENOCARCINOMA; PARANEOPLASTIC PEMPHIGUS; PATHOGENESIS; PEMPHIGUS; PLASMAPHERESIS; PROGNOSIS; PROSTATE ADENOCARCINOMA; PROTEIN FAMILY; RASH; RETICULOSARCOMA; REVIEW; SARCOMA; SEPSIS; SQUAMOUS CELL CARCINOMA; STEM CELL TRANSPLANTATION; THYMOMA; TONGUE CARCINOMA; TUMOR CELL; TUMOR IMMUNITY; WALDENSTROEM MACROGLOBULINEMIA;

EID: 77950575896     PISSN: 10278117     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1027-8117(10)60001-8     Document Type: Review

References (124)

1. Anhalt G.J., Kim S.C., Stanley J.R., et al. Paraneoplastic pemphigus: an autoimmune mucocutaneous disease associated with neoplasia. N Engl J Med 323 (1990) 1729-1735
2. Nguyen V.T., Ndoye A., Bassler K.D., et al. Classification, clinical manifestations, and immunopathological mechanisms of the epithelial variant of paraneoplastic autoimmune multiorgan syndrome: a reappraisal of paraneoplastic pemphigus. Arch Dermatol 137 (2001) 193-206
3. Kaplan I., Hodak E., Ackerman L., et al. Neoplasms associated with paraneoplastic pemphigus: A review with emphasis on nonhematologic malignancy and oral mucosal manifestations. Oral Oncol 40 (2004) 553-562
4. Chamberland M. Paraneoplastic pemphigus and adenocarcinoma of the colon. Union Med Can 122 (1993) 201-203 [In French]
5. Joly P., Thomine E., Gilbert D., et al. Overlapping distribution of autoantibody specificities in paraneoplastic pemphigus and pemphigus vulgaris. J Invest Dermatol 103 (1994) 65-72
6. Rongioletti F., Truchetet F., and Rebora A. Paraneoplastic pemphigoid- pemphigus? Subepidermal bullous disease with pemphigus-like direct immunofluorescence. Int J Dermatol 32 (1993) 48-51
7. Matz H., Milner Y., Frusic-Zlotkin M., et al. Paraneoplastic pemphigus associated with pancreatic carcinoma. Acta Derm Venereol 77 (1997) 289-291
8. Bowen G.M., Peters N.T., Fivenson D.P., et al. Lichenoid dermatitis in paraneoplastic pemphigus: a pathogenic trigger of epitope spreading?. Arch Dermatol 136 (2000) 652-656
9. Martel P., Gilbert D., Labeille B., et al. A case of paraneoplastic pemphigus with antidesmoglein 1 antibodies as determined by immunoblotting. Br J Dermatol 142 (2000) 812-813
10. Mignogna M.D., Fortuna G., Leuci S., et al. Metastatic prostate cancer presenting as paraneoplastic pemphigus: a favourable clinical response to combined androgen blockade and conventional immunosuppressive therapy. Br J Dermatol 160 (2009) 468-470
11. Hinterhuber G., Drach J., Riedl E., et al. Paraneoplastic pemphigus in association with hepatocellular carcinoma. J Am Acad Dermatol 49 (2003) 538-540
12. Yokokura H., Demitsu T., Kakurai M., et al. Paraneoplastic pemphigus mimicking erosive mucosal lichen planus associated with primary hepatocellular carcinoma. J Dermatol 33 (2006) 842-845
13. Wong K.C., and Ho K.K. Pemphigus with pemphigoid-like presentation, associated with squamous cell carcinoma of the tongue. Australas J Dermatol 41 (2000) 178-180
14. Niimi Y., Kawana S., Hashimoto T., et al. Paraneoplastic pemphigus associated with uterine carcinoma. J Am Acad Dermatol 48 (2003) S69-S72
15. Aessopos A., Grapsa A., Farmakis D., et al. Oral paraneoplastic pemphigus associated with renal malignancy. Acta Derm Venereol 83 (2003) 72-73
16. Lam S., Stone M.S., Goeken J.A., et al. Paraneoplastic pemphigus, cicatricial conjunctivitis, and acanthosis nigricans with pachydermatoglyphy in a patient with bronchogenic squamous cell carcinoma. Ophthalmology 99 (1992) 108-113
17. Perniciaro C., Kuechle M.K., Colon-Otero G., et al. Paraneoplastic pemphigus: a case of prolonged survival. Mayo Clin Proc 69 (1994) 851-855
18. Schaeppi H., Bauer J.W., Hametner R., et al. A localized variant of paraneoplastic pemphigus: acantholysis associated with malignant melanoma. Br J Dermatol 144 (2001) 1249-1254
19. De Saint Paul G., Albes B., Bayle P., et al. Cutaneous T-cell lymphoma, cutaneous hyperpigmentation and paraneoplastic pemphigus. Ann Dermatol Venereol 129 (2002) 896-900 [In French]
20. Wang J., Bu D.F., Li T., et al. Autoantibody production from a thymoma and a follicular dendritic cell sarcoma associated with paraneoplastic pemphigus. Br J Dermatol 153 (2005) 558-564
21. Lee I.J., Kim S.C., Kim H.S., et al. Paraneoplastic pemphigus associated with follicular dendritic cell sarcoma arising from Castleman's tumor. J Am Acad Dermatol 40 (1999) 294-297
22. Marzano A.V., Vezzoli P., Mariotti F., et al. Paraneoplastic pemphigus associated with follicular dendritic cell sarcoma and Castleman disease. Br J Dermatol 153 (2005) 214-215
23. Seishima M., Oda M., Oyama Z., et al. Antibody titers to desmogleins 1 and 3 in a patient with paraneoplastic pemphigus associated with follicular dendritic cell sarcoma. Arch Dermatol 140 (2004) 1500-1503
24. Gironet N., De Muret A., Machet L., et al. Paraneoplastic pemphigus revealing dendritic cell sarcoma originating from Castleman's disease of the neck. Ann Dermatol Venereol 132 (2005) 41-44
25. Lee S.E., Kim H.R., Hashimoto T., et al. Paraneoplastic pemphigus developed shortly after resection of follicular dendritic cell sarcoma. Acta Derm Venereol 88 (2008) 410-412
26. Meijs M., Mekkes J., van Noesel C., et al. Paraneoplastic pemphigus associated with follicular dendritic cell sarcoma without Castleman's disease; treatment with rituximab. Int J Dermatol 47 (2008) 632-634
27. Santi C.G., Flores R.S., Medina M.M., et al. Paraneoplastic pemphigus associated with pelvic inflammatory fibrosarcoma: a case report. J Dermatol 32 (2005) 1014-1020
28. Lee D.H., Lee S.H., and Sung J.K. Inflammatory myofibroblastic tumor on intercostal nerve presenting as paraneoplastic pemphigus with fatal pulmonary involvement. J Korean Med Sci 22 (2007) 735-739
29. Kahawita I.P., Fernando M.S., Sirimanna G.M., et al. Paraneoplastic pemphigus associated with inflammatory myofibroblastic tumor. Int J Dermatol 45 (2006) 1394-1396
30. Schoen H., Foedinger D., Derfler K., et al. Immunoapheresis in paraneoplastic pemphigus. Arch Dermatol 134 (1998) 706-710
31. Krunic A.L., Kokai D., Bacetic B., et al. Retroperitoneal round-cell liposarcoma associated with paraneoplastic pemphigus presenting as lichen planus pemphigoides-like eruption. Int J Dermatol 36 (1997) 526-529
32. van der Waal R.I., Pas H.H., Nousari H.C., et al. Paraneoplastic pemphigus caused by an epithelioid leiomyosarcoma and associated with fatal respiratory failure. Oral Oncol 36 (2001) 390-393
33. Beele H., Claerhout I., Kestelyn P., et al. Bilateral corneal melting in a patient with paraneoplastic pemphigus. Dermatology 202 (2001) 147-150
34. Berg W.A., Fishman E.K., and Anhalt G.J. Retroperitoneal reticulum cell sarcoma: a cause of paraneoplastic pemphigus. South Med J 86 (1993) 215-217
35. Lemon M.A., Weston W.L., and Huff J.C. Childhood paraneoplastic pemphigus associated with Castleman's tumour. Br J Dermatol 136 (1997) 115-117
36. Anhalt G.J. Paraneoplastic pemphigus. J Investig Dermatol Symp Proc 9 (2004) 29-33
37. Ostezan L.B., Fabre V.C., Caughman S.W., et al. Paraneoplastic pemphigus in the absence of a known neoplasm. J Am Acad Dermatol 33 (1995) 312-315
38. Park G.T., Lee J.H., Yun S.J., et al. Paraneoplastic pemphigus without an underlying neoplasm. Br J Dermatol 156 (2007) 563-566
39. Verrini A., Cannata G., Cozzani E., et al. A patient with immunological features of paraneoplastic pemphigus in the absence of a detectable malignancy. Acta Derm Venereol 82 (2002) 382-384
40. Joly P., Richard C., Gilbert D., et al. Sensitivity and specificity of clinical, histologic, and immunologic features in the diagnosis of paraneoplastic pemphigus. J Am Acad Dermatol 43 (2000) 619-626
41. Wade M.S., and Black M.M. Paraneoplastic pemphigus: a brief update. Australas J Dermatol 46 (2005) 1-8
42. Wang J., Zhu X., Li R., et al. Paraneoplastic pemphigus associated with Castleman tumor: a commonly reported subtype of paraneoplastic pemphigus in China. Arch Dermatol 141 (2005) 1285-1293
43. Meyers S.J., Varley G.A., Meisler D.M., et al. Conjunctival involvement in paraneoplastic pemphigus. Am J Ophthalmol 114 (1992) 621-624
44. Sugar A. Paraneoplastic pemphigus and ophthalmology. Ophthalmology 99 (1992) 5-6
45. Lam S., Stone M.S., Goeken J.A., et al. Paraneoplastic pemphigus, cicatricial conjunctivitis, and acanthosis nigricans with pachydermatoglyphy in a patient with bronchogenic squamous cell carcinoma. Ophthalmology 99 (1992) 108-113
46. Miida H., Kazama T., Inomata N., et al. Severe gastrointestinal involvement in paraneoplastic pemphigus. Eur J Dermatol 16 (2006) 420-422
47. Billet S.E., Grando S.A., and Pittelkow M.R. Paraneoplastic autoimmune multiorgan syndrome: review of the literature and support for a cytotoxic role in pathogenesis. Autoimmunity 39 (2006) 617-630
48. Kim S.C., Chang S.N., Lee I.J., et al. Localized mucosal involvement and severe pulmonary involvement in a young patient with paraneoplastic pemphigus associated with Castleman's tumour. Br J Dermatol 138 (1998) 667-671
49. Bialy-Golan A., Brenner S., and Anhalt G.J. Paraneoplastic pemphigus: oral involvement as the sole manifestation. Act Derm Venereol 76 (1996) 253-254
50. Wang L., Bu D., Yang Y., et al. Castleman's tumours and production of autoantibody in paraneoplastic pemphigus. Lancet 363 (2004) 525-531
51. Cummins D.L., Mimouni D., Tzu J., et al. Lichenoid paraneoplastic pemphigus in the absence of detectable antibodies. J Am Acad Dermatol 56 (2007) 153-159
52. Fukumoto T., Shiroyama Y., Niizeki H., et al. Paraneoplastic pemphigus presenting as erythrodermic lichenoid dermatitis with concomitant features of pemphigus foliaceus. J Dermatol 34 (2007) 645-649
53. Lee S.E., Hashimoto T., and Kim S.C. No mucosal involvement in a patient with paraneoplastic pemphigus associated with thymoma and myasthenia gravis. Br J Dermatol 159 (2008) 986-988
54. Mimouni D., Anhalt G.J., Lazarova Z., et al. Paraneoplastic pemphigus in children and adolescents. Br J Dermatol 147 (2002) 725-732
55. Zuo Y.G., Wang B.X., Ma D.L., et al. Mechanism of alopecia in patients with paraneoplastic pemphigus. Zhongguo Yi Xue Ke Xue Yuan Xue Bao 27 (2005) 354-356 [In Chinese]
56. Hashimoto T. Immunopathology of paraneoplastic pemphigus. Clin Dermatol 19 (2001) 675-682
57. Kim S.C., Kwon Y.D., Lee I.J., et al. cDNA cloning of the 210-kDa paraneoplastic pemphigus antigen reveals that envoplakin is a component of the antigen complex. J Invest Dermatol 109 (1997) 365-369
58. Mahoney M.G., Aho S., Uitto J., et al. The members of the plakin family of proteins recognized by paraneoplastic pemphigus antibodies include periplakin. J Invest Dermatol 111 (1998) 308-313
59. Amagai M., Nishikawa T., Nousari H.C., et al. Antibodies against desmoglein 3 (pemphigus vulgaris antigen) are present in sera from patients with paraneoplastic pemphigus and cause acantholysis in vivo in neonatal mice. J Clin Invest 102 (1998) 775-782
60. Ruhrberg C., Hajibagheri M.A., Parry D.A., et al. Periplakin, a novel component of cornified envelopes and desmosomes that belongs to the plakin family and forms complexes with envoplakin. J Cell Biol 139 (1997) 1835-1849
61. Sonnenberg A., and Liem R.K. Plakins in development and disease. Exp Cell Res 313 (2007) 2189-2203
62. Kanitakis J. Indirect immunofluorescence microscopy for the serological diagnosis of autoimmune blistering skin diseases: a review. J Clin Dermatol 19 (2001) 614-621
63. Anhalt G.J. Paraneoplastic pemphigus. Adv Dermatol 12 (1997) 77-96
64. Kimyai-Asadi A., and Jih M.H. Paraneoplastic pemphigus. Int J Dermatol 40 (2001) 367-372
65. Harman K.E., Gratian M.J., Bhogal B.S., et al. The use of two substrates to improve the sensitivity of indirect immunofluorescence in the diagnosis of pemphigus. Br J Dermatol 145 (2001) 178-182
66. Helou J., Allbritton J., and Anhalt G. Accuracy of indirect immunofluorescence in the diagnosis of paraneoplastic pemphigus. J Am Acad Dermatol 32 (1995) 441-447
67. Liu A.Y., Valenzuela R., Helm T.N., et al. Indirect immunofluorescence on rat bladder transitional epithelium: a test with high specificity for paraneoplastic pemphigus. J Am Acad Dermatol 28 (1993) 696-699
68. Hashimoto T., Amagai M., Watanabe K., et al. Characterization of paraneoplastic pemphigus auto-antigens by immunoblot analysis. J Invest Dermatol 104 (1995) 829-834
69. Laffitte E., Favre B., Fontao L., et al. Plectin, an unusual target antigen in bullous pemphigoid. Br J Dermatol 144 (2001) 136-138
70. Amagai M., Komai A., Hashimoto T., et al. Usefulness of enzyme-linked immunosorbent assay using recombinant desmogleins 1 and 3 for serodiagnosis of pemphigus. Br J Dermatol 140 (1999) 351-357
71. Ishii N., Maeyama Y., Karashima T., et al. Immunoserological analyses of 55 patients with pemphigus at the Dermatological Department of Kurume University Hospital: an 11-year retrospective study (1996-2006). Int J Dermatol 47 (2008) 1321-1322
72. Zhang B., Zheng R., Wang J., et al. Epitopes in the linker subdomain region of envoplakin recognized by autoantibodies in paraneoplastic pemphigus patients. J Invest Dermatol 126 (2006) 832-840
73. Huang Y., Li J., and Zhu X. Detection of anti-envoplakin and anti-periplakin autoantibodies by ELISA in patients with paraneoplastic pemphigus. Arch Dermatol Res 301 (2009) 703-709
74. Mouquet H., Drenovska K., Lartigue A., et al. Detection and characterization of anti-envoplakin linker autoantibodies in paraneo-plastic pemphigus using specific bead-based assay. Clin Immunol 129 (2008) 304-312
75. Camisa C., Helm T.N., Liu Y.C., et al. Paraneoplastic pemphigus: a report of three cases including one long-term survivor. J Am Acad Dermatol 27 (1992) 547-553
76. Robinson N., Hashimoto T., Amagai M., et al. The new pemphigus variants. J Am Acad Dermatol 40 (1999) 649-671
77. Zhu X., and Zhang B. Paraneoplastic pemphigus. J Dermatol 34 (2007) 503-511
78. Ashinoff R., Cohen R., and Lipkin G. Castleman's tumor and erosive lichen planus: coincidence or association? Report of a case. J Am Acad Dermatol 21 (1989) 1076-1080
79. Chan L.S., Vanderlugt C.J., Hashimoto T., et al. Epitope spreading: lessons from autoimmune skin diseases. J Invest Dermatol 110 (1998) 103-109
80. Powell A.M., and Black M.M. Epitope spreading: protection from pathogens, but propagation of autoimmunity?. Clin Exp Dermatol 26 (2001) 427-433
81. Davis A.L., Bhogal B.S., Whitehead P., et al. Lichen planus pemphigoides: its relationship to bullous pemphigoid. Br J Dermatol 125 (1991) 263-271
82. Kirtschig G., Chow E.T., Venning V.A., et al. Acquired subepidermal bullous diseases associated with psoriasis: a clinical, immunopathological and immunogenetic study. Br J Dermatol 135 (1996) 738-745
83. Chan L.S., Soong H.K., Foster C.S., et al. Ocular cicatricial pemphigoid occurring as a sequela of Stevens-Johnson syndrome. JAMA 266 (1991) 1543-1546
84. Papanicolaou D.A., Wilder R.L., Manolagas S.C., et al. The pathophysiologic roles of interleukin-6 in human disease. Ann Int Med 128 (1998) 127-137
85. Nousari H.C., Kimyai-Asadi A., and Anhalt G.J. Elevated levels of interleukin-6 in paraneoplastic pemphigus. J Invest Dermatol 112 (1999) 396-398
86. Yee C., Biondi A., Wang X.H., et al. A possible autocrine role for interleukin-6 in two lymphoma cell lines. Blood 74 (1989) 798-804
87. Diehl L.F., and Ketchum L.H. Autoimmune disease and chronic lymphocytic leukemia. Autoimmune hemolytic anemia, pure red cell aplasia, and autoimmune thrombocytopenia. Semin Oncol 25 (1998) 80-97
88. Beck J.T., Hsu S.M., Wijdenes J., et al. Alleviation of systemic manifestations of Castleman's disease by monoclonal anti-interleukin-6 antibody. New Engl J Med 330 (1994) 602-605
89. Wang J., Bu D.F., and Zhu X.J. Immunoglobulin variable region gene rearrangement and hypermutation in paraneoplastic pemphigus associated Castleman's tumor. Beijing Da Xue Xue Bao 36 (2004) 454-461 [In Chinese]
90. Wang J., and Zhu X.J. The new development on pathogenesis of autoimmune paraneoplastic pemphigus. Beijing Da Xue Xue Bao 36 (2004) 540-543 [In Chinese]
91. Nishifuji K., Olivry T., Ishii K., et al. IgG autoantibodies directed against desmoglein 3 cause dissociation of keratinocytes in canine pemphigus vulgaris and paraneoplastic pemphigus. Vet Immunol Immunopathol 117 (2007) 209-221
92. Nguyen V.T., Ndoye A., Shultz L.D., et al. Antibodies against keratinocyte antigens other than desmogleins 1 and 3 can induce pemphigus vulgaris-like lesions. J Clin Invest 106 (2000) 1467-1479
93. Inaoki M., Kodera M., Fujimoto A., et al. Paraneoplastic pemphigus without antidesmoglein 3 or antidesmoglein 1 autoantibodies. Br J Dermatol 144 (2001) 610-613
94. Foedinger D., Elbe-Bürger A., Sterniczky B., et al. Erythema multi-forme associated human autoantibodies against desmoplakin I and II: biochemical characterization and passive transfer studies into newborn mice. J Invest Dermatol 111 (1998) 503-510
95. Li J., Bu D.F., Huang Y.C., et al. Role of autoantibodies against the linker subdomains of envoplakin and periplakin in the pathogenesis of paraneoplastic pemphigus. Chin Med J 122 (2009) 486-495
96. Reich K., Brinck U., Letschert M., et al. Graft-versus-host disease-like immunophenotype and apoptotic keratinocyte death in paraneoplastic pemphigus. Br J Dermatol 141 (1999) 739-746
97. Iho S., Shau H., and Golub S.H. IL-6 enhances the cytotoxic activity of thymocyte-derived CD56 + cells. Cell Immunol 144 (1992) 1-10
98. Nakashima M., Watanabe T., Koprowski H., et al. In vitro expansion of tumor-specific, HLA-restricted human CD8 + cytolytic T lymphocytes. Cell Immunol 155 (1994) 53-61
99. Majeski E.I., Paintlia M.K., Lopez A.D., et al. Respiratory reovirus 1/L induction of intraluminal fibrosis, a model of bronchiolitis obliterans organizing pneumonia, is dependent on T lymphocytes. Am J Pathol 163 (2003) 1467-1479
100. Dega H., Laporte J.L., Joly P., et al. Paraneoplastic pemphigus associated with Hodgkin's disease. Br J Dermatol 138 (1998) 196-198
101. Martínez D., Pablo M.I., Iranzo P., et al. Paraneoplastic pemphigus associated with non-Hodgkin B-cell lymphoma and good response to prednisone. Acta Derm Venereol 85 (2005) 233-235
102. Gergely L., Váróczy L., Vadász G., et al. Successful treatment of B cell chronic lymphocytic leukemia-associated severe paraneo-plastic pemphigus with cyclosporin A. Acta Haematol 109 (2003) 202-205
103. Hertzberg M.S., Schifter M., Sullivan J., et al. Paraneoplastic pemphigus in two patients with B-cell non-Hodgkin's lymphoma: significant responses to cyclophosphamide and prednisolone. Am J Hematol 63 (2000) 105-106
104. Hayag M.V., Cohen J.A., and Kerdel F.A. Immunoablative highdose cyclophosphamide without stem cell rescue in a patient with pemphigus vulgaris. J Am Acad Dermatol 43 (2000) 1065-1069
105. Williams J.V., Marks J.G., and Billingsley E.M. Use of mycophenolate mofetil in the treatment of paraneoplastic pemphigus. Br J Dermatol 142 (2000) 506-508
106. Mazzi G., Raineri A., Zanolli F.A., et al. Plasmapheresis therapy in pemphigus vulgaris and bullous pemphigoid. Transfus Apheresis Sci 28 (2003) 13-18
107. Izaki S., Yoshizawa Y., Kitamura K., et al. Paraneoplastic pemphigus: potential therapeutic effect of plasmapheresis. Br J Dermatol 134 (1996) 987-989
108. Tan-Lim R., and Bystryn J.C. Effect of plasmapheresis therapy on circulating levels of pemphigus antibodies. J Am Acad Dermatol 22 (1990) 35-40
109. Hohwy T., Bang K., Steiniche T., et al. Alemtuzumab-induced remission of both severe paraneoplastic pemphigus and leukaemic bone marrow infiltration in a case of treatment-resistant B-cell chronic lymphocytic leukaemia. Eur J Haematol 73 (2004) 206-209
110. Barbetakis N., Samanidis G., Paliouras D., et al. Paraneoplastic pemphigus regression after thymoma resection. World J Surg Oncol 6 (2008) 83 [Published online]
111. Hainsworth J.D., Burris H.A., Morrissey L.H., et al. Rituximab monoclonal antibody as initial systemic therapy for patients with low-grade non-Hodgkins lymphoma. Blood 95 (2000) 3052-3056
112. Schmidt E., Bröcker E.B., and Goebeler M. Rituximab in treatment-resistant autoimmune blistering skin disorders. Clin Rev Allergy Immunol 34 (2008) 56-64
113. Heizmann M., Itin P., Wernli M., et al. Successful treatment of paraneoplastic pemphigus in follicular NHL with rituximab: report of a case and review of treatment for paraneoplastic pemphigus in NHL and CLL. Am J Haematol 66 (2001) 142-144
114. Borradori L., Lombardi T., Samson J., et al. Anti-Cd20 monoclonal antibody (rituximab) for refractory erosive stomatitis secondary to CD20 (+) follicular lymphomaassociated paraneoplastic pemphigus. Arch Dermatol 137 (2001) 269-272
115. Ahmed A.R., Avram M.M., and Duncan L.M. Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 23-2003. A 79-year-old woman with gastric lymphoma and erosive mucosal and cutaneous lesions. N Engl J Med 349 (2003) 382-391
116. Rossum M.M., Verhaegen N.T.M., Jonkman M.F., et al. Follicular non-Hodgkin's lymphoma with refractory paraneoplastic pemphigus: case report with review of novel treatment modalities. Leukaemia Lymphoma 45 (2004) 2327-2332
117. Hoque S.R., Black M.M., and Cliff S. Paraneoplastic pemphigus associated with CD20-positive follicular non-Hodgkin's lymphoma treated with rituximab: a third case resistant to rituximab therapy. Clin Exp Dermatol 32 (2007) 172-175
118. Barnadas M., Roe E., Brunet S., et al. Therapy of paraneoplastic pemphigus with Rituximab: a case report and review of literature. J Eur Acad Dermatol Venereol 20 (2006) 69-74
119. Schadlow M.B., Anhalt G.J., and Sinha A.A. Using rituximab (anti-CD20 antibody) in a patient with paraneoplastic pemphigus. J Drugs Dermatol 2 (2003) 564-567
120. Meijs M., Mekkes J., van Noesel C., et al. Paraneoplastic pemphigus associated with follicular dendritic cell sarcoma without Castleman's disease; treatment with rituximab. Int J Dermatol 47 (2008) 632-634
121. Nikolskaia O.V., Nousari C.H., and Anhalt G.J. Paraneoplastic pemphigus in association with Castleman's disease. Br J Dermatol 149 (2003) 1143-1151
122. Nousari H.C., Deterding R., Wojtczack H., et al. The mechanism of respiratory failure in paraneoplastic pemphigus. N Engl J Med 340 (1999) 1406-1410
123. Hoffman M.A., Qiao X., and Anhalt G.J. CD8 + T lymphocytes in bronchiolitis obliterans, paraneoplastic pemphigus, and solitary Castleman's disease. N Engl J Med 349 (2003) 407-408
124. Chin A.C., Stich D., White F.V., et al. Paraneoplastic pemphigus and bronchiolitis obliterans associated with a mediastinal mass: a rare case of Castleman's disease with respiratory failure requiring lung transplantation. J Pediatr Surg 36 (2001) E22